Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous (IV) formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretic therapy. ## Adult Dosing * **Oral:** * For treatment of hypokalemia: Typically 20-100 mEq per day, divided into 1-4 doses. Maximum daily dose can be up to 200 mEq but requires careful monitoring. * For prevention of hypokalemia: Typically 20-40 mEq per day, divided into 1-2 doses. * **Intravenous (IV):** * For treatment of hypokalemia: Dosing is highly individualized based on serum potassium levels, ECG findings, and clinical status. Mild hypokalemia (serum K < 3.0 mEq/L) may be treated with 10-20 mEq/hour. Severe or symptomatic hypokalemia or serum K < 2.0 mEq/L may require higher infusion rates (up to 40 mEq/hour) and higher concentrations, often requiring central venous access. **IV administration rates and concentrations must be determined by local protocol and physician order due to significant risks.** ## Pediatric Dosing * **Oral:** * For treatment of hypokalemia: 2-5 mEq/kg/day, divided into 1-4 doses. Maximum daily dose up to 10 mEq/kg/day. * For prevention of hypokalemia: 1-2 mEq/kg/day. * **Intravenous (IV):** * Dosing is highly individualized and dependent on serum potassium levels and clinical condition. **IV potassium should be administered with extreme caution in pediatric patients. Always refer to specific institutional protocols and physician orders.** Generally, infusion rates should not exceed 10-20 mEq/kg/hour or 1 mEq/kg/hour for peripheral administration, with maximum concentrations typically limited to 40 mEq/L peripherally and up to 80 mEq/L centrally. ## Dose Adjustments * Renal impairment: Use with caution and reduce dose as potassium is renally excreted. Monitor serum potassium closely. ## Contraindications * Hyperkalemia. * Conditions leading to increased potassium levels (e.g., severe renal impairment, untreated Addison's disease, severe burns, crush injuries). * Known hypersensitivity to potassium chloride. * Certain gastrointestinal conditions (e.g., esophageal compression, delayed gastric emptying) may contraindicate solid oral dosage forms. ## Adverse Effects * **Most Serious:** Hyperkalemia (potentially life-threatening), cardiac arrhythmias, cardiac arrest. * **Common:** Nausea, vomiting, diarrhea, abdominal pain. * **Less Common:** Vein irritation (IV), phlebitis (IV), paresthesia. ## Key Drug Interactions * **ACE inhibitors, ARBs, potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, cyclosporine, tacrolimus:** Increased risk of hyperkalemia. * **Insulin, beta-agonists:** Can shift potassium intracellularly, potentially masking or reducing the effectiveness of potassium replacement. * **Diuretics (loop, thiazide):** Can increase potassium loss, requiring increased potassium intake. ## Monitoring * Serum potassium levels (frequently, especially with IV administration or rapid changes in dose). * Renal function (BUN, creatinine). * ECG for signs of hyperkalemia (peaked T waves, prolonged PR interval, widened QRS). * Signs and symptoms of hypokalemia (muscle weakness, fatigue, cramps, constipation) and hyperkalemia (numbness, tingling, muscle weakness, palpitations). * Fluid balance and urine output. ## Clinical Pearls * Oral potassium chloride should be administered with food or a meal to minimize gastrointestinal upset. * Dilute concentrated IV potassium solutions appropriately before administration to prevent vein irritation and tissue damage. * Never administer IV potassium chloride as a bolus injection; it must be infused slowly and continuously. * Patients with significant renal impairment require very careful dose titration and close monitoring of potassium levels. * The risk of hyperkalemia is increased in the elderly and in patients with heart failure. *** *Disclaimer: This information is intended for healthcare professionals and is not a substitute for clinical judgment or current prescribing information. Always consult the official drug monograph and local protocols for the most up-to-date and comprehensive information before prescribing or administering any medication.*